The 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Chicago
18 MAY 2018Presentations and Publications
Read about publications and presentations made by Benitec's scientific team below. For details of Benitec's announcements to NASDAQ, read details in our Investor Centre.2018
BB-301: A Single “Silence and Replace” AAV-Based Vector for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)
2017
Towards Development of a ‘Silence and Replace’ Based Approach for the Treatment of Oculopharyngeal Muscular Dystrophy
European Society of Gene & Cell Therapy (ESGCT) Congress, Berlin
18 OCT 2017
Gene therapy for oculopharyngeal muscular dystrophy
The 22nd International Annual Congress of the World Muscle Society
6 OCT 2017